Deals & Cases | 26 October 2026 Distalmotion SA – USD 70 million Term Loan Facility from Perceptive Advisors
Deals & Cases | 19 August 2026 Oversubscribed USD 152 Million Series B Financing Round of Vaderis Therapeutics
Deals & Cases | 16 June 2026 Walder Wyss advises VERAXA Biotech AG on successful Business Combination and NASDAQ Listing
Deals & Cases | 18 March 2026 Biotech Company CRISPR Therapeutics (NASDAQ) issued USD 600M Convertible Notes
